|Author (Corporate)||European Commission: DG Health and Food Safety|
|Series Details||COM (2021) 355|
|Content Type||Blog, News, Policy-making|
Communication published by the European Commission on 6 May 2021, setting out a strategy focusing on the development and availability of COVID-19 (coronavirus) therapeutics, including the treatment of the so-called long COVID condition.
The strategy aims to cover the full lifecycle of medicines - from research, development and manufacturing to procurement and deployment. It includes a set of actions and targets on a number of fields:
On 29 June 2021, the European Commission announced the first portfolio of five therapeutics in the framework of this strategy.
|Subject Tags||Medicines | Medical Devices|
|International Organisations||European Union [EU]|